Literature DB >> 11803092

How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review.

Zarko Alfirevic1, Devender Roberts, Vanessa Martlew.   

Abstract

OBJECTIVE: To determine whether inherited and acquired thrombophilias are associated with adverse obstetric complications. STUDY
DESIGN: A systematic review; studies where women with adverse obstetric complications were tested for one or more acquired and inherited thrombophilias were included. MAIN OUTCOME MEASURES: Prevalence of thrombophilia in women with severe pre-eclampsia/eclampsia, severe placental abruption, intrauterine growth restriction or unexplained stillbirth.
RESULTS: Compared with controls, placental abruption was more often associated with homozygous and heterozygous factor V Leiden mutation, heterozygous G20210A prothrombin gene mutation, homocysteinaemia, activated protein C resistance or anticardiolipin IgG antibodies. Women with pre-eclampsia/eclampsia were more likely to have heterozygous factor V Leiden mutation, heterozygous G20210A prothrombin gene mutation, homozygous MTHFR C677T mutation, protein C deficiency, protein S deficiency or activated protein C resistance compared with controls. Unexplained stillbirth, when compared with controls, was more often associated with heterozygous factor V Leiden mutation, protein S deficiency, activated protein C resistance, anticardiolipin IgG antibodies or lupus anticoagulant. Women with intrauterine growth restriction had a higher prevalence of heterozygous G20210A prothrombin gene mutation, homozygous MTHFR C677T gene mutation, protein S deficiency or anticardiolipin IgG antibodies than controls. There was wide heterogeneity in the prevalence of thrombophilia between the studies.
CONCLUSIONS: Women with adverse pregnancy outcome are more likely to have a positive thrombophilia screen but studies published so far are too small to adequately assess the true size of this association. Screening for thrombophilia should not become standard practice until clear evidence emerges that thromboprophylaxis during pregnancy improves perinatal outcome. Further research into the link between the observed association, causality and heterogeneity is required.

Entities:  

Mesh:

Year:  2002        PMID: 11803092     DOI: 10.1016/s0301-2115(01)00496-1

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  41 in total

1.  The Normal anticoagulant system and risk of placental abruption: protein C, protein S and resistance to activated protein C.

Authors:  Cande V Ananth; Carl A Nath; Claire Philipp
Journal:  J Matern Fetal Neonatal Med       Date:  2010-03-24

Review 2.  Intravenous immunoglobulin and recurrent pregnancy loss.

Authors:  Howard J A Carp; Tal Sapir; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

Review 3.  Fetal and umbilical Doppler ultrasound in high-risk pregnancies.

Authors:  Zarko Alfirevic; Tamara Stampalija; Gillian M L Gyte
Journal:  Cochrane Database Syst Rev       Date:  2013-11-12

Review 4.  Fetal and umbilical Doppler ultrasound in high-risk pregnancies.

Authors:  Zarko Alfirevic; Tamara Stampalija; Therese Dowswell
Journal:  Cochrane Database Syst Rev       Date:  2017-06-13

5.  Puerperal ovarian vein thrombosis: two case reports.

Authors:  Marta Angelini; Giovanni Barillari; Ambrogio P Londero; Serena Bertozzi; Sergio Bernardi; Roberto Petri; Lorenza Driul; Diego Marchesoni
Journal:  J Thromb Thrombolysis       Date:  2013-02       Impact factor: 2.300

6.  Inherited thrombophilia is significantly associated with severe preeclampsia.

Authors:  Roxana Elena Bohiltea; Monica Mihaela Cirstoiu; Natalia Turcan; Anca Pantea Stoian; Corina-Aurelia Zugravu; Octavian Munteanu; Luciana Valentina Arsene; Bodean Oana; Adrian Neacsu; Florentina Furtunescu
Journal:  Exp Ther Med       Date:  2021-01-25       Impact factor: 2.447

Review 7.  Prophylaxis for venous thromboembolic disease in pregnancy and the early postnatal period.

Authors:  Rebecca Tooher; Simon Gates; Therese Dowswell; Lucy-Jane Davis
Journal:  Cochrane Database Syst Rev       Date:  2010-05-12

Review 8.  Fetal and umbilical Doppler ultrasound in high-risk pregnancies.

Authors:  Zarko Alfirevic; Tamara Stampalija; Gillian Ml Gyte
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

9.  Prothrombin gene variants in non-Caucasians with fetal loss and intrauterine growth retardation.

Authors:  Iris Schrijver; Tiffanee J Lenzi; Carol D Jones; Marla J Lay; Maurice L Druzin; James L Zehnder
Journal:  J Mol Diagn       Date:  2003-11       Impact factor: 5.568

10.  Thrombin regulates soluble fms-like tyrosine kinase-1 (sFlt-1) expression in first trimester decidua: implications for preeclampsia.

Authors:  Charles J Lockwood; Paolo Toti; Felice Arcuri; Errol Norwitz; Edmund F Funai; Se-Te J Huang; Lynn F Buchwalder; Graciela Krikun; Frederick Schatz
Journal:  Am J Pathol       Date:  2007-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.